Abstract 1602P
Background
When a child has a life-limiting, irreversible condition such as advanced cancer, a healthcare team and family may decide to limit care lacking clear benefit. In such circumstances, a compassionate extubation, or discontinuation of life-sustaining ventilator support allowing natural death, may be pursued. Compassionate extubations are an infrequently performed procedure with complexities that include difficult conversations and dynamic symptom management which can lend to this being a challenging process to execute, particularly without opportunity for practice. Simulation can be a helpful tool to enhance knowledge, confidence, and preparedness with unfamiliar or uncommon scenarios in a safe environment. A compassionate extubation simulation training experience focusing on the conversational and technical skills was implemented within the Pediatric Intensive Care Unit at an academic medical center in New York City. The aim of the project was to determine whether participation in one simulation training improved healthcare providers’ confidence with performing a compassionate extubation.
Methods
A one group pretest-posttest design project was implemented using The Confidence Scale to evaluate RN and APRN confidence with performing a compassionate extubation before and after the simulation. The sample was described using descriptive statistical analysis and the Wilcoxon signed-rank test was used to evaluate for differences between first and second observations.
Results
A Wilcoxon signed-rank test determined that the compassionate extubation simulation elicited a statistically significant median increase in C-Scale scores after participation in the simulation (median = 20) compared to C-Scale scores prior (median = 12), W = 45, p = 0.007.
Conclusions
Affording opportunity for healthcare providers to sculpt and refine their practice with certain challenging clinical scenarios has been shown to improve their confidence navigating these situations. All efforts to improve confidence related to sensitive situations such as with a compassionate extubation are made with the intention of improving the experience of children at the end of their lives as well as the experiences of the families and loved ones who walk this journey with them.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2018P - Novel nomogram based on the expression of DLL3 and PD-L1 for predicting the prognosis of small cell lung cancer patients
Presenter: Jun Zhao
Session: Poster session 05
2019P - Analysis of lung immune prognostic index (LIPI) score in a small cell lung cancer carcinoma (SCLC) cohort, supporting its prognostic use and investigating its predictive potential
Presenter: Mónica Esteban García
Session: Poster session 05
2020P - Circulating micro RNAs (cmiRNAs) as treatment outcome predictors in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab plus carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2021P - Cell-free (cf) DNA as predictive biomarker (B) of treatment outcome in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab, carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2022P - ALBA project: Prognostic impact of laterality in small cell lung cancer
Presenter: Lorenza Landi
Session: Poster session 05
2024P - Supportive measures to control myelosuppression and costs for patients with SCLC with lurbinectedin, CAV or topotecan with or without trilaciclib: A review on the basis of clinical trials
Presenter: Manuel Dómine
Session: Poster session 05
2025P - Stratified control study of neuroendocrine differentiation and potential clinicopathologic markers
Presenter: Li Liu
Session: Poster session 05
2026P - Small cell lung cancer (SCLC) in the KBP-2020-CPHG cohort and comparison with 2000 and 2010
Presenter: Lionel Falchero
Session: Poster session 05
2027P - Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
Presenter: Patsy Lee
Session: Poster session 05